The food and drug agency of Indonesia has approved the single-dose COVID-19 vaccine of US pharmaceutical company Johnson and Johnson (NYSE:JNJ) for emergency use, Reuters news agency reported on Tuesday.
This vaccine is produced by Janssen Pharmaceutical Companies, a part of Johnson & Johnson.
The agency has also approved emergency use of Chinese vaccine company CanSino Biological Inc's (HKG:6185) COVID-19 vaccine.
Bavarian Nordic files for chikungunya vaccine approval in Europe
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
Philippine lawmakers call for probe into secret US propaganda operation
Gavi seeking funding to immunise poorest children
Sanofi partners with Biovac to manufacture polio vaccines in Africa
Scancell Holdings announces evaluation agreement with major biotechnology company
CSL Seqirus to provide pre-pandemic vaccines to EU
YS Biopharma's YS-HBV-002 receives Philippine clinical trial approval
Anixa Biosciences adds Dr Sanjay Juneja to Cancer Business Advisory Board
Circio ends TG01 cancer vaccine licence deal with IOVaxis in China